Stay updated on Intratumoral G100 in NHL Clinical Trial
Sign up to get notified when there's something new on the Intratumoral G100 in NHL Clinical Trial page.

Latest updates to the Intratumoral G100 in NHL Clinical Trial page
- Check2 days agoChange DetectedNo additions or deletions were detected in the page content. The study overview, eligibility criteria, and plan remain unchanged from prior version.SummaryDifference0.3%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange Detected- Added a government funding notice with operational details and links; - Updated version to v3.2.0; - Removed reference to v3.1.0.SummaryDifference2%

- Check31 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.0%

- Check45 days agoChange DetectedPage version updated to v3.0.2; the 'Back to Top' link was removed. No other content changes were detected.SummaryDifference0.1%

- Check52 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.SummaryDifference0.1%

- Check59 days agoChange DetectedThe web page has been updated to include a new facility name and location, along with specific medical terms related to follicular lymphoma and various antibodies, while several previous terms and topics have been removed.SummaryDifference2%

Stay in the know with updates to Intratumoral G100 in NHL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intratumoral G100 in NHL Clinical Trial page.